Ladenburg Thalmann Financial Services’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$33K	Buy	865 +365	+73%	+$10.9K	﹤0.01%	3809
2019 Q3	$12K	Sell	500 -1,800	-78%	-$48.9K	﹤0.01%	4291
2019 Q2	$66K	Hold	2,300	–	–	﹤0.01%	3258
2019 Q1	$65K	Hold	2,300	–	–	﹤0.01%	3215
2018 Q4	$53K	Hold	2,300	–	–	﹤0.01%	3201
2018 Q3	$79K	Sell	2,300 -23,621	-91%	-$797K	﹤0.01%	2987
2018 Q2	$849K	Hold	25,921	–	–	0.01%	1161
2018 Q1	$849K	Buy	25,921 +21,421	+476%	+$699K	0.01%	1161
2017 Q4	$128K	Buy	4,500 +1,500	+50%	+$42K	﹤0.01%	2531
2017 Q3	$87K	Hold	3,000	–	–	﹤0.01%	2692
2017 Q2	$72K	Buy	3,000 +100	+3%	+$2.24K	﹤0.01%	2735
2017 Q1	$67K	Sell	2,900 -200	-6%	-$4.25K	﹤0.01%	2676
2016 Q4	$57K	Sell	3,100 -550	-15%	-$11K	﹤0.01%	2743
2016 Q3	$83K	Sell	3,650 -651	-15%	-$13.3K	﹤0.01%	2389
2016 Q2	$77K	Sell	4,301 -200	-4%	-$3.92K	﹤0.01%	2345
2016 Q1	$86K	Hold	4,501	–	–	﹤0.01%	2167
2015 Q4	$131K	Sell	4,501 -499	-10%	-$14.4K	﹤0.01%	1868
2015 Q3	$132K	Buy	5,000 +2,800	+127%	+$94.7K	﹤0.01%	1789
2015 Q2	$80K	Buy	+2,200	New	+$75.6K	﹤0.01%	2253

Other funds holding BBC

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

AWCI

Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return

RWB

RMR Wealth Builders Montclair, New Jersey $1.27B AUM 19.16% 1-Year Est. Return

Ladenburg Thalmann Financial Services's BBC Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Virtus Biotech Clinical Trials ETF (BBC) stake by 73% in Q4 2019, buying an estimated $10.9K and bringing the position to 865 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #3809.

Ladenburg Thalmann Financial Services first reported a position in BBC in Q2 2015 and has held it in 19 quarters since. The position peaked at $849K in Q2 2018. 16 funds tracked by Wall St. Rank hold BBC as of Q4 2019.

Ladenburg Thalmann Financial Services held 865 shares of Virtus Biotech Clinical Trials ETF worth $33K as of Q4 2019.
Ladenburg Thalmann Financial Services bought 365 Virtus Biotech Clinical Trials ETF shares in Q4 2019, an estimated $10.9K.
Virtus Biotech Clinical Trials ETF made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #3809 holding.
Ladenburg Thalmann Financial Services first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2015 and has held it in 19 quarters since.
Ladenburg Thalmann Financial Services's Virtus Biotech Clinical Trials ETF position peaked at $849K in Q2 2018.
16 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.